HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Business Round-Up: Stada Enters Germany Top-5, Dr Wolff Takes Vagisan To Poland, Fidia And Sanova Strike Nasal Spray Deals

Executive Summary

Acquiring six brands from GSK has propelled Stada into Germany's OTC top-5; Dr. Wolff has secured distribution for its Vagisan women's health brand in Poland; and Sanova and Fidia have added innovative nasal sprays to their respective portfolios.

You may also be interested in...



EU Business Round-Up: Galderma Divests To Dallman’s, Oysershell names CEO, Ceres Acquires

Latest business news in the EU: Galderma offloads German Bübchen brand to Dallman's; Belgium's Oystershell names experienced CEO; Ceres Pharma snaps up Romania's Viva.

Stada Grabs GSK Brands In Key EU Markets

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.

OTC And Cosmetics R&D Drive Dr Wolff’s 2019 Success

Alpecin hair-loss shampoo manufacturer Dr Wolff achieved positive results in OTC and cosmetics categories in 2019 from increased R&D investment. 

Topics

UsernamePublicRestriction

Register

SC100339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel